Marrone Bio Innovations, Inc.
MBII
MBII was delisted on the 12th of July, 2022.
23 hedge funds and large institutions have $13.6M invested in Marrone Bio Innovations, Inc. in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 4 closing their positions.
25% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 4
5% more funds holding
Funds holding: 22 → 23 (+1)
10% less capital invested
Capital invested by funds: $15.1M → $13.6M (-$1.56M)
67% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$83.9K |
| 2 |
ACM
Azimuth Capital Management
Bloomfield Hills,
Michigan
|
+$39.8K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
+$26.4K |
| 4 |
VF
Virtu Financial
New York
|
+$23.3K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$12.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$200K |
| 2 |
SIM
Spark Investment Management
New York
|
-$53.9K |
| 3 |
Primecap Management
Pasadena,
California
|
-$53.8K |
| 4 |
SC
Savant Capital
Rockford,
Illinois
|
-$14K |
| 5 |
BlackRock
New York
|
-$3.47K |
MBII Hedge Fund Activity: Q3 2017 in Review
23 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Marrone Bio Innovations, Inc. (MBII) for Q3 2017, worth a combined $13.6M — down 10% from $15.1M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new MBII positions and 4 closed out — a net gain of 1 holder — while 2 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $83.9K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $200K sold.
- 23 institutional investors held Marrone Bio Innovations, Inc. (MBII) as of Q3 2017, up from 22 in Q2 2017.
- Funds reported $13.6M of Marrone Bio Innovations, Inc. stock for Q3 2017, down 10% quarter-over-quarter.
- 5 funds opened new Marrone Bio Innovations, Inc. positions in Q3 2017 and 4 closed out, a net change of +1 holder.
- The largest Marrone Bio Innovations, Inc. buyer in Q3 2017 was Vanguard Group, an estimated $83.9K added.
- The largest Marrone Bio Innovations, Inc. seller in Q3 2017 was Bridgeway Capital Management, an estimated $200K sold.
Based on aggregated 13F filings for Q3 2017.